This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Fiducial Markers Market

Market Insights on Fiducial Markers covering sales outlook, demand forecast & up-to-date key trends

Fiducial Markers Market By Product (Polymer-based, Metal-based, Pure Gold, Liquid-based), Modality (Photon Therapy, Proton Therapy, Tomotherapy, Cyberknife), Disease Site (Head & Neck, Breasts, Lungs, Abdomen, Prostate, Kidneys, Cervix or Other Gynecologic Organs) & Region - Forecast 2022 - 2028

Fiducial Markers Market Outlook (2022-2028)

[331 Pages Report] The global market for fiducial markers is predicted to expand at a high 8.4% CAGR, reaching a value of US$ 226.7 Mn by 2028, up from US$ 139.6 Mn in 2022.

Fiducial Markers Market Size (2022)

US$ 139.6 Mn

Revenue Forecast (2028)

US$ 226.7 Mn

Global Market Growth Rate (2022-2028)

8.4% CAGR

Dominant Product Type

Pure Gold Markers (64.5%)

Fiducial markers currently account for 1.5% share in the global radiotherapy market. The global fiducial markers market is predicted to rise as the use of radiotherapy in cancer treatment becomes more common.

Customize this Report

Let us know your requirement to get
100% FREE customization

Demand Analysis of Fiducial Markers (2013 to 2021) Vs Market Outlook (2022 to 2028)

The fiducial markers market expanded at a CAGR of 8.7% from 2013 to 2021 and amassed revenue worth US$ 127 Mn in 2021.

Fiducial markers are very small devices, around the size of rice grains that can target tumors or malignant areas while leaving healthy tissues alone.

A fiducial marker is a device used in radiotherapy to designate the surgical region and provide precise radiation dosage. Percutaneous fiducial markers placement has been attempted, but it has been linked to a high rate of pneumothorax and chest drain placement.

Fiducial markers placement can be done simply and safely via bronchoscopy. The fiducial marker can help the doctor pinpoint the exact location of the tumor and give the patient the right amount of radiation without hurting the tissue.

Fiducial markers come in a variety of forms such as polymer-based markers, metal-based markers, and many others. The fiducial marker technology may also provide a 3D picture of fiducials as well as a report with the exact diagnosis and treatment plan.

Fiducial markers in radiotherapy are basically used to detect lung tumours. They are also known as lung fiducial markers. Pneumothorax or collapsed lung is a problem that occurs when the air becomes trapped between the lung and the chest wall after lung fiducial markers are implanted. The air pocket may need to be removed and the lung re-expanded, which may necessitate the placement of a chest tube.

Fiducial Markers Market Download Report Brochure

Prostate fiducial markers are used in the treatment of patients suffering from prostate cancer. Wrong Implementation of prostate fiducial markers in the prostate may be led to rectal bleeding, blood in urine, or discomfort or stinging when urinating. Prostate cancer is the world's second most prevalent cancer among males. As a result, the need for prostate fiducial markers is on the rise.

While modern lifestyles, lack of healthy behavior, and other factors have elevated cancer risks, adoption of cutting-edge technology in hospitals, hospital outpatient facilities, and medical sectors has fuelled the rise of fiducial marker producers over the last decade. Manufacturers and suppliers are expected to see increased demand in the coming years as demand for fiducial markers in radiotherapy grows.

The sales of fiducial markers are being fuelled by rising cancer rates and greater awareness about early detection and adequate treatment. Demand for fiducial markers for diseases such as lung cancer, stomach cancer, prostate cancer, tumors, and others is rapidly increasing as producers focus on providing a broader range of products.

Fiducial marker demand is predicted to surge at a CAGR of 8.4% from 2022 to 2028, with the global market expected to reach a valuation of US$ 226.7 Mn by 2028.

Which Factors are Liable for Increasing Sales of Fiducial Markers?

“Rapid Increase in Cancer Cases Surging Demand for Fiducial Markers”

In image-based radiotherapy, fiducial markers are utilised to target cancerous tissues while leaving healthy tissues unaffected. Globally, the demand for fiducial markers is increasing due to an increase in cancer diagnoses. Cancer is the greatest cause of mortality worldwide, accounting for about 10 million deaths in 2020, or nearly one in every six deaths, according to the WHO.

Lung and breast cancers are the most common cancers among adults worldwide, with over 4 million cases each. As a result, healthcare institutions and governments are stepping up their efforts to create highly complex techniques to alleviate the strain.

Evidence suggests that intensive radiation treatments help patients with Stage IV non-small cell lung cancer that have only a few metastases outside the lungs live longer. Open surgery, on the other hand, has been shown to be successful in treating cervical cancers in their early stages. Fiducial markers are in high demand as a result of this.

“Increasing Cancer Treatment Centers, Especially Hospitals, Driving Sales of Fiducial Markers”

Due to increased demand from hospitals, which are highly advanced in terms of diagnosis and treatment, are strengthening the growth of fiducial marker producers. Governments and non-profit organisations are increasing their spending in research and development, sophisticated medical equipment, and other items for hospitals, which is fuelling demand for fiducial markers.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What are the Major Challenges Faced by Fiducial Marker Producers?

“High Cost of Fiducial Markers May Dent Market Growth”

Fiducial markers are generally expensive and out of budget for most people. As a result, commoners may be unable to pay the high cost of operation, limiting the expansion of the fiducial markers market.

Furthermore, there are various disadvantages to using fiducial markers. Because of the invasive nature of this surgery, it is not appropriate for all individuals. Furthermore, fiducial markers cause image quality to be distorted during scanning, making tumor identification difficult. Lack of knowledge is also one reason which limits the market growth.

Which Regions are Most Productive for Fiducial Marker Providers?

“High Investment in R&D & Presence of Key Players Make North America a Dominant Region for Fiducial Markers”

These fiducial markers market insights provide data for North America, Latin America, Europe, East Asia, South Asia & Pacific, and the Middle East & Africa (MEA).

North America is expected to hold a notable market share in the global fiducial markers market because of the rising prevalence of cancer, the presence of a large number of major players, growing research and development expenditure, rising patient awareness and preference for radiotherapy, reimbursement policies, and technological advancements

Europe is predicted to be the second-largest market for fiducial markers, with a revenue share that is identical to North America. The availability of strong governmental frameworks by respective governments in Europe helps in fostering advanced cancer diagnosis and therapy research.

The European Society for Medical Oncology is a key regulatory body that oversees the implementation of best clinical practice standards while treating cancer patients. Since the COVID-19 pandemic breakout, the foundation has provided a huge help to oncology specialists.

A patient with hepatocellular carcinoma (HCC) should be given special attention by implementing methods such as virtualization of appointments, home blood sample and drug administration, and intravenous therapy. All of this is increasing the market for fiducial markers in Europe.

Because of the expanding opportunities for lung and throat cancer therapies, in the Asia Pacific market, East Asia is likely to provide viable expansion opportunities. This is primarily due to an increase in mortality as a result of excessive tobacco use.

More than a quarter of the population in East Asia over the age of 15 is addicted to smoking. Inevitably, deaths are increasing at an exponential rate. As a result, respective governments and healthcare providers are investing in innovative cancer treatment techniques, paving the path for higher fiducial marker sales within the forecast period.

Upcoming regions are the Latin America market and the MEA market for fiducial markers.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Country-wise Analysis

Why are Manufacturers of Fiducial Markers Eyeing the U.S. Market?

“Increasing Cancer Cases Driving Number of Fiducial Marker Manufacturing Units”

The United States is the market leader in North America for fiducial markers, due to a rising number of cancer institutions, radiation centres, and highly developed manufacturing units. According to Cancer Facts & Figures (2022), an educational companion to Cancer Statistics (2022), a scientific publication published in the American Cancer Society journal, the United States will see 1.9 Mn new cancer cases diagnosed and 609,360 cancer deaths in 2022.

The market for fiducial markers is likely to gain pace in the United States of America in the coming decade as a result of these advancements.  Also, rising sales of fiducial markers in the U.S. and the presence of key manufacturers are fuelling the market growth.

What are the Possibilities for Manufacturers of Fiducial Markers in China?

“Implementation of Advanced Technologies in Cancer Treatment & Increasing Number of Cancer Patients”

In terms of cancer diagnosis and treatment, China is well ahead of the rest of the world. Fiducial marker producers have benefited greatly from the incorporation of cutting-edge technologies in cancer treatment.

According to data published by PubMed.gov, in 2022 China would have 4,820,000 new cancer cases and 3,210,000 cancer deaths. Lung cancer is the most frequent cancer in China. In China, rates of stomach, liver, and esophageal cancer have gradually declined, but rates of colorectal cancer in the general population, prostate cancer in males, and other seven cancer types in women have climbed.

Increases in adult population size and population ageing were important predictors of incremental cancer deaths and several cancer types, while lower case-fatality rates contributed to lowered cancer deaths in the country. Thus, these factors result in the rapid growth of the fiducial markers market during the forecast period.

Category-wise Analysis

Which Fiducial Marker is Most Popular?

“Effective Results of Pure Gold Fiducial Markers Makes them Prominent Product”

  • Pure gold fiducial markers now lead the market, and this position is likely to hold during the forecast period. Pure gold fiducial markers are expected to account for 64.5% of the market share in the global landscape in 2022, with the rest of the market accounted for by polymer-based fiducial markers, pure gold fiducial markers, and liquid-based fiducial markers.

For patients with the prostate cancer type, use of intraprostatic gold fiducial markers allows highly accurate and exact image-guided radiation therapy. Radiologists choose these for the treatment of lung, breast, and other forms of malignancies.

Pure gold fiducial markers are most likely to be used in a range of cancer treatment processes. Target visibility during external beam radiation and brachytherapy treatments is greatly improved by using gold fiducial markers. It also helped patients feel better.

The Gold Anchor Marker is made by InnoMedicus, a well-known manufacturer of distinctive fiducial markers. It's widely utilised for Cyberknife treatments of the lungs, liver, adrenal gland, pancreas, and prostate gland, to name a few. Gold markers are likely to be used in more than six out of ten cancer surgeries.

Polymer-based markers, metal-based markers, and liquid-based markers are other significant product groups that are driving manufacturer sales. Metal-based markers will account for 20.3% of the global market share in 2022, while polymer-based markers & liquid-based markers, together, will account for 15.1% share.

COVID-19 Impact on Market

The worldwide healthcare environment was profoundly transformed by the new coronavirus outbreak. With great pressure being imposed across global hospital infrastructures, important healthcare businesses are accelerating attempts to develop promising vaccines and treatments. Despite this, the market for fiducial markers remained robust due to the continued availability of cancer treatment.

Use of radiation therapy has increased dramatically in recent months. Initially, surgeons were afraid that, because radiation therapy is delivered in fractions, patients would have to return to the hospital multiple times, increasing their risk of infection. Because of this fear, hospital outpatient facilities and other healthcare providers have begun to plan virtual consultations and postpone in-person appointments when they are not necessary.

Only individuals with life-threatening illnesses who need to be operated on go to hospitals and hospital outpatient facilities, which keeps the need for fiducial markers high. However, as restrictions and the spread of COVID-19 infection have decreased, the fiducial markers market is expected to reach its full potential over the projection period.

Competitive Landscape

The global market for fiducial markers is rapidly growing. Eckert & Ziegler BEBIG, Innovative Oncology Solutions, Boston Scientific, IBA Dosimetry, Best Medical International, Inc., Carbon Medical Technologies, CIVCO, alphaXRT, Nanovi A/S, Stellar Medical, and others are profiled in detail in this fiducial markers market report.

  • Key businesses are emphasising the launch of more high-quality products to survive in the cutthroat market competition.
  • Companies are also using additional competitive methods such as active involvement in conferences, seminars, and other promotional events to raise knowledge about their products.

Fiducial Markers Industry Report Scope

Attribute

Details

Forecast Period

2022-2028

Historical Data Available for

2013-2021

Market Analysis

US$ Mn for Value

Key Regions Covered

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa (MEA)

Key Countries Covered

  • United States
  • Canada
  • Brazil
  • Mexico
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • China
  • Japan
  • South Korea
  • India
  • Indonesia
  • Malaysia
  • Singapore
  • Australia
  • New Zealand
  • Turkey
  • South Africa
  • and GCC Countries

Key Market Segments Covered

  • Product
  • Modality
  • Disease Site
  • End Use
  • Region

Key Companies Profiled

Pricing

Available upon Request

Key Segments of Fiducial Markers Industry Survey

Fiducial Markers Market by Product:

  • Polymer-based Fiducial Markers
  • Metal-based Fiducial Markers
  • Pure Gold Fiducial Markers
  • Liquid-based Fiducial Markers

Fiducial Markers Market by Modality:

  • Photon Therapy
  • Proton Therapy
  • Tomotherapy
  • Cyberknife

Fiducial Markers Market by Disease Site:

  • Head & Neck
  • Breasts
  • Lungs
  • Abdomen
  • Prostate
  • Kidneys
  • Cervix or Other Gynecologic Organs

Fiducial Markers Market by End Use:

  • Hospitals
  • Cancer Research Institutes
  • Radiotherapy Centers

Fiducial Markers Market by Region:

  • North America Fiducial Markers Market
  • Latin America Fiducial Markers Market
  • Europe Fiducial Markers Market
  • East Asia Fiducial Markers Market
  • South Asia & Pacific Fiducial Markers Market
  • Middle East & Africa (MEA) Fiducial Markers Market

Frequently Asked Questions

The global fiducial markers market is currently valued at around US$ 139.6 Mn and is predicted to reach US$ 226.7 Mn by 2028.

The global fiducial markers market is estimated to expand at a CAGR of 8.4% through 2028.

Key companies providing fiducial markers include Eckert & Ziegler BEBIG, Innovative Oncology Solutions, Boston Scientific, IBA Dosimetry, Best Medical International, Inc., Carbon Medical Technologies, CIVCO, alphaXRT, Nanovi A/S, and Stellar Medical.

North America is the largest regional market for fiducial markers.

Pure gold fiducial markers are highly sought-after across regions.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity 

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Regulatory Landscape

    3.4. Reimbursement Guidelines

    3.5. PESTLE and Porter’s Analysis

    3.6. Value Chain Analysis

4. Global Fiducial Markers Market Analysis 2015-2021 and Forecast, 2022-2030

    4.1. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis, 2015-2021

    4.2. Current and Future Market Size Value (US$ Mn) & Volume (Units) Projections, 2022-2030

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Fiducial Markers Market Analysis 2015-2021 and Forecast 2022-2030, By Product Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Product Type, 2015-2021

    5.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Product Type, 2022-2030

        5.3.1. Polymer Based Markers

        5.3.2. Metal Based Markers

        5.3.3. Pure Gold Markers

        5.3.4. Liquid Based Markers

    5.4. Y-o-Y Growth Trend Analysis By Product Type, 2015-2021

    5.5. Absolute $ Opportunity Analysis By Product Type, 2022-2030

6. Global Fiducial Markers Market Analysis 2015-2021 and Forecast 2022-2030, By Modality

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Mn) Analysis By Modality, 2015-2021

    6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Modality, 2022-2030

        6.3.1. Proton Therapy

        6.3.2. Photon Therapy

        6.3.3. Tomotherapy

        6.3.4. Cyber knife

        6.3.5. Magnetic Resonance Imaging

        6.3.6. Linac

        6.3.7. Others

    6.4. Y-o-Y Growth Trend Analysis By Modality, 2015-2021

    6.5. Absolute $ Opportunity Analysis By Modality, 2022-2030

7. Global Fiducial Markers Market Analysis 2015-2021 and Forecast 2022-2030, By Disease Site

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Mn) Analysis By Disease Site, 2015-2021

    7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Disease Site, 2022-2030

        7.3.1. Head & Neck

        7.3.2. Breast

        7.3.3. Lung

        7.3.4. Abdomen

        7.3.5. Prostrate

        7.3.6. Kidney

        7.3.7. Cervix or Other Gynecological Organs

    7.4. Y-o-Y Growth Trend Analysis By Disease Site, 2015-2021

    7.5. Absolute $ Opportunity Analysis By Disease Site, 2022-2030

8. Global Fiducial Markers Market Analysis 2015-2021 and Forecast 2022-2030, By End Users

    8.1. Introduction / Key Findings

    8.2. Historical Market Size Value (US$ Mn) Analysis By End Users, 2015-2021

    8.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End Users, 2022-2030

        8.3.1. Hospitals

        8.3.2. Cancer Research Institutes

        8.3.3. Radiotherapy Centers

    8.4. Y-o-Y Growth Trend Analysis By End Users, 2015-2021

    8.5. Absolute $ Opportunity Analysis By End Users, 2022-2030

9. Global Fiducial Markers Market Analysis 2015-2021 and Forecast 2022-2030, By Region

    9.1. Introduction

    9.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Region, 2015-2021

    9.3. Current Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Region, 2022-2030

        9.3.1. North America

        9.3.2. Latin America

        9.3.3. Europe

        9.3.4. East Asia

        9.3.5. South Asia

        9.3.6. Oceania

        9.3.7. Middle East & Africa (MEA)

    9.4. Market Attractiveness Analysis By Region

10. North America Fiducial Markers Market Analysis 2015-2021 and Forecast 2022-2030, By Country

    10.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2015-2021

    10.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2030

        10.2.1. By Country

            10.2.1.1. U.S.

            10.2.1.2. Canada

        10.2.2. By Product Type

        10.2.3. By Modality

        10.2.4. By Disease Site

        10.2.5. By End Users

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product Type

        10.3.3. By Modality

        10.3.4. By Disease Site

        10.3.5. By End Users

    10.4. Key Takeaways

11. Latin America Fiducial Markers Market Analysis 2015-2021 and Forecast 2022-2030, By Country

    11.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2015-2021

    11.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2030

        11.2.1. By Country

            11.2.1.1. Brazil

            11.2.1.2. Mexico

            11.2.1.3. Argentina

            11.2.1.4. Rest of Latin America

        11.2.2. By Product Type

        11.2.3. By Modality

        11.2.4. By Disease Site

        11.2.5. By End Users

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product Type

        11.3.3. By Modality

        11.3.4. By Disease Site

        11.3.5. By End Users

    11.4. Key Takeaways

12. Europe Fiducial Markers Market Analysis 2015-2021 and Forecast 2022-2030, By Country

    12.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2015-2021

    12.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2030

        12.2.1. By Country

            12.2.1.1. Germany

            12.2.1.2. Italy

            12.2.1.3. France

            12.2.1.4. U.K.

            12.2.1.5. Spain

            12.2.1.6. Russia

            12.2.1.7. BENELUX

            12.2.1.8. Rest of Europe

        12.2.2. By Product Type

        12.2.3. By Modality

        12.2.4. By Disease Site

        12.2.5. By End Users

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product Type

        12.3.3. By Modality

        12.3.4. By Disease Site

        12.3.5. By End Users

    12.4. Key Takeaways

13. East Asia Fiducial Markers Market Analysis 2015-2021 and Forecast 2022-2030, By Country

    13.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2015-2021

    13.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2030

        13.2.1. By Country

            13.2.1.1. China

            13.2.1.2. Japan

            13.2.1.3. South Korea

        13.2.2. By Product Type

        13.2.3. By Modality

        13.2.4. By Disease Site

        13.2.5. By End Users

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product Type

        13.3.3. By Modality

        13.3.4. By Disease Site

        13.3.5. By End Users

    13.4. Key Takeaways

14. South Asia Fiducial Markers Market Analysis 2015-2021 and Forecast 2022-2030, By Country

    14.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2015-2021

    14.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2030

        14.2.1. By Country

            14.2.1.1. India

            14.2.1.2. Thailand

            14.2.1.3. Malaysia

            14.2.1.4. Indonesia

            14.2.1.5. Rest of South Asia

        14.2.2. By Product Type

        14.2.3. By Modality

        14.2.4. By Disease Site

        14.2.5. By End Users

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Product Type

        14.3.3. By Modality

        14.3.4. By Disease Site

        14.3.5. By End Users

    14.4. Key Takeaways

15. Oceania Fiducial Markers Market Analysis 2015-2021 and Forecast 2022-2030, By Country

    15.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2015-2021

    15.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2030

        15.2.1. By Country

            15.2.1.1. Australia

            15.2.1.2. New Zealand

        15.2.2. By Product Type

        15.2.3. By Modality

        15.2.4. By Disease Site

        15.2.5. By End Users

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Product Type

        15.3.3. By Modality

        15.3.4. By Disease Site

        15.3.5. By End Users

    15.4. Key Takeaways

16. Middle East & Africa (MEA) Fiducial Markers Market Analysis 2015-2021 and Forecast 2022-2030, By Country

    16.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2015-2021

    16.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2030

        16.2.1. By Country

            16.2.1.1. GCC

            16.2.1.2. Turkey

            16.2.1.3. South Africa

            16.2.1.4. Rest of MEA

        16.2.2. By Product Type

        16.2.3. By Modality

        16.2.4. By Disease Site

        16.2.5. By End Users

    16.3. Market Attractiveness Analysis

        16.3.1. By Country

        16.3.2. By Product Type

        16.3.3. By Modality

        16.3.4. By Disease Site

        16.3.5. By End Users

    16.4. Key Takeaways

17. Key Countries Fiducial Markers Market Analysis

    17.1. Japan

        17.1.1. Pricing Analysis

        17.1.2. Market Share Analysis, 2021

            17.1.2.1. By Product Type

            17.1.2.2. By Modality

            17.1.2.3. By Disease Site

            17.1.2.4. By End Users

    17.2. China

        17.2.1. Pricing Analysis

        17.2.2. Market Share Analysis, 2021

            17.2.2.1. By Product Type

            17.2.2.2. By Modality

            17.2.2.3. By Disease Site

            17.2.2.4. By End Users

    17.3. Australia

        17.3.1. Pricing Analysis

        17.3.2. Market Share Analysis, 2021

            17.3.2.1. By Product Type

            17.3.2.2. By Modality

            17.3.2.3. By Disease Site

            17.3.2.4. By End Users

18. Market Structure Analysis

    18.1. Competition Dashboard

    18.2. Competition Benchmarking

    18.3. Market Share Analysis of Top Players

        18.3.1. By Regional

        18.3.2. By Product Type

        18.3.3. By Modality

        18.3.4. By Disease Site

        18.3.5. By End Users

19. Competition Analysis

    19.1. Competition Deep Dive

        19.1.1. Eckert & Zieglar BEBIG

            19.1.1.1. Overview

            19.1.1.2. Product Portfolio

            19.1.1.3. SWOT Analysis

            19.1.1.4. Sales Footprint

            19.1.1.5. Strategy Overview

                19.1.1.5.1. Marketing Strategy

                19.1.1.5.2. Product Strategy

                19.1.1.5.3. Channel Strategy

        19.1.2. Innovative Oncology Solutions

            19.1.2.1. Overview

            19.1.2.2. Product Portfolio

            19.1.2.3. SWOT Analysis

            19.1.2.4. Sales Footprint

            19.1.2.5. Strategy Overview

                19.1.2.5.1. Marketing Strategy

                19.1.2.5.2. Product Strategy

                19.1.2.5.3. Channel Strategy

        19.1.3. Boston Scientific

            19.1.3.1. Overview

            19.1.3.2. Product Portfolio

            19.1.3.3. SWOT Analysis

            19.1.3.4. Sales Footprint

            19.1.3.5. Strategy Overview

                19.1.3.5.1. Marketing Strategy

                19.1.3.5.2. Product Strategy

                19.1.3.5.3. Channel Strategy

        19.1.4. IBA

            19.1.4.1. Overview

            19.1.4.2. Product Portfolio

            19.1.4.3. SWOT Analysis

            19.1.4.4. Sales Footprint

            19.1.4.5. Strategy Overview

                19.1.4.5.1. Marketing Strategy

                19.1.4.5.2. Product Strategy

                19.1.4.5.3. Channel Strategy

        19.1.5. Best Medical International, Inc.

            19.1.5.1. Overview

            19.1.5.2. Product Portfolio

            19.1.5.3. SWOT Analysis

            19.1.5.4. Sales Footprint

            19.1.5.5. Strategy Overview

                19.1.5.5.1. Marketing Strategy

                19.1.5.5.2. Product Strategy

                19.1.5.5.3. Channel Strategy

        19.1.6. IZI Medical Products

            19.1.6.1. Overview

            19.1.6.2. Product Portfolio

            19.1.6.3. SWOT Analysis

            19.1.6.4. Sales Footprint

            19.1.6.5. Strategy Overview

                19.1.6.5.1. Marketing Strategy

                19.1.6.5.2. Product Strategy

                19.1.6.5.3. Channel Strategy

        19.1.7. Carbon Medical Technologies

            19.1.7.1. Overview

            19.1.7.2. Product Portfolio

            19.1.7.3. SWOT Analysis

            19.1.7.4. Sales Footprint

            19.1.7.5. Strategy Overview

                19.1.7.5.1. Marketing Strategy

                19.1.7.5.2. Product Strategy

                19.1.7.5.3. Channel Strategy

        19.1.8. CIVCO

            19.1.8.1. Overview

            19.1.8.2. Product Portfolio

            19.1.8.3. SWOT Analysis

            19.1.8.4. Sales Footprint

            19.1.8.5. Strategy Overview

                19.1.8.5.1. Marketing Strategy

                19.1.8.5.2. Product Strategy

                19.1.8.5.3. Channel Strategy

        19.1.9. AlphaXRT

            19.1.9.1. Overview

            19.1.9.2. Product Portfolio

            19.1.9.3. SWOT Analysis

            19.1.9.4. Sales Footprint

            19.1.9.5. Strategy Overview

                19.1.9.5.1. Marketing Strategy

                19.1.9.5.2. Product Strategy

                19.1.9.5.3. Channel Strategy

        19.1.10. Nanovi A/S

            19.1.10.1. Overview

            19.1.10.2. Product Portfolio

            19.1.10.3. SWOT Analysis

            19.1.10.4. Sales Footprint

            19.1.10.5. Strategy Overview

                19.1.10.5.1. Marketing Strategy

                19.1.10.5.2. Product Strategy

                19.1.10.5.3. Channel Strategy

        19.1.11. Stellar Medical

            19.1.11.1. Overview

            19.1.11.2. Product Portfolio

            19.1.11.3. SWOT Analysis

            19.1.11.4. Sales Footprint

            19.1.11.5. Strategy Overview

                19.1.11.5.1. Marketing Strategy

                19.1.11.5.2. Product Strategy

                19.1.11.5.3. Channel Strategy

20. Assumptions & Acronyms Used

21. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Fiducial Markers Market Value (US$ Mn) Forecast by Region, 2015-2030

Table 2: Global Fiducial Markers Market Volume (Units) Forecast by Region, 2015-2030

Table 3: Global Fiducial Markers Market Value (US$ Mn) Forecast by Product Type, 2015-2030

Table 4: Global Fiducial Markers Market Volume (Units) Forecast by Product Type, 2015-2030

Table 5: Global Fiducial Markers Market Value (US$ Mn) Forecast by Modality, 2015-2030

Table 6: Global Fiducial Markers Market Volume (Units) Forecast by Modality, 2015-2030

Table 7: Global Fiducial Markers Market Value (US$ Mn) Forecast by Disease Site, 2015-2030

Table 8: Global Fiducial Markers Market Volume (Units) Forecast by Disease Site, 2015-2030

Table 9: Global Fiducial Markers Market Value (US$ Mn) Forecast by End Users, 2015-2030

Table 10: Global Fiducial Markers Market Volume (Units) Forecast by End Users, 2015-2030

Table 11: North America Fiducial Markers Market Value (US$ Mn) Forecast by Country, 2015-2030

Table 12: North America Fiducial Markers Market Volume (Units) Forecast by Country, 2015-2030

Table 13: North America Fiducial Markers Market Value (US$ Mn) Forecast by Product Type, 2015-2030

Table 14: North America Fiducial Markers Market Volume (Units) Forecast by Product Type, 2015-2030

Table 15: North America Fiducial Markers Market Value (US$ Mn) Forecast by Modality, 2015-2030

Figure 16: Global Fiducial Markers Market Value Share (%) and BPS Analysis by Modality, 2022-2030

Table 17: North America Fiducial Markers Market Value (US$ Mn) Forecast by Disease Site, 2015-2030

Table 18: North America Fiducial Markers Market Volume (Units) Forecast by Disease Site, 2015-2030

Table 19: North America Fiducial Markers Market Value (US$ Mn) Forecast by End Users, 2015-2030

Table 20: North America Fiducial Markers Market Volume (Units) Forecast by End Users, 2015-2030

Table 21: Latin America Fiducial Markers Market Value (US$ Mn) Forecast by Country, 2015-2030

Table 22: Latin America Fiducial Markers Market Volume (Units) Forecast by Country, 2015-2030

Table 23: Latin America Fiducial Markers Market Value (US$ Mn) Forecast by Product Type, 2015-2030

Table 24: Latin America Fiducial Markers Market Volume (Units) Forecast by Product Type, 2015-2030

Table 25: Latin America Fiducial Markers Market Value (US$ Mn) Forecast by Modality, 2015-2030

Table 26: Latin America Fiducial Markers Market Volume (Units) Forecast by Modality, 2015-2030

Table 27: Latin America Fiducial Markers Market Value (US$ Mn) Forecast by Disease Site, 2015-2030

Table 28: Latin America Fiducial Markers Market Volume (Units) Forecast by Disease Site, 2015-2030

Table 29: Latin America Fiducial Markers Market Value (US$ Mn) Forecast by End Users, 2015-2030

Table 30: Latin America Fiducial Markers Market Volume (Units) Forecast by End Users, 2015-2030

Table 31: Europe Fiducial Markers Market Value (US$ Mn) Forecast by Country, 2015-2030

Table 32: Europe Fiducial Markers Market Volume (Units) Forecast by Country, 2015-2030

Table 33: Europe Fiducial Markers Market Value (US$ Mn) Forecast by Product Type, 2015-2030

Table 34: Europe Fiducial Markers Market Volume (Units) Forecast by Product Type, 2015-2030

Table 35: Europe Fiducial Markers Market Value (US$ Mn) Forecast by Modality, 2015-2030

Table 36: Europe Fiducial Markers Market Volume (Units) Forecast by Modality, 2015-2030

Table 37: Europe Fiducial Markers Market Value (US$ Mn) Forecast by Disease Site, 2015-2030

Table 38: Europe Fiducial Markers Market Volume (Units) Forecast by Disease Site, 2015-2030

Table 39: Europe Fiducial Markers Market Value (US$ Mn) Forecast by End Users, 2015-2030

Table 40: Europe Fiducial Markers Market Volume (Units) Forecast by End Users, 2015-2030

Table 41: East Asia Fiducial Markers Market Value (US$ Mn) Forecast by Country, 2015-2030

Table 42: East Asia Fiducial Markers Market Volume (Units) Forecast by Country, 2015-2030

Table 43: East Asia Fiducial Markers Market Value (US$ Mn) Forecast by Product Type, 2015-2030

Table 44: East Asia Fiducial Markers Market Volume (Units) Forecast by Product Type, 2015-2030

Table 45: East Asia Fiducial Markers Market Value (US$ Mn) Forecast by Modality, 2015-2030

Table 46: East Asia Fiducial Markers Market Volume (Units) Forecast by Modality, 2015-2030

Table 47: East Asia Fiducial Markers Market Value (US$ Mn) Forecast by Disease Site, 2015-2030

Table 48: East Asia Fiducial Markers Market Volume (Units) Forecast by Disease Site, 2015-2030

Table 49: East Asia Fiducial Markers Market Value (US$ Mn) Forecast by End Users, 2015-2030

Table 50: East Asia Fiducial Markers Market Volume (Units) Forecast by End Users, 2015-2030

Table 51: South Asia Fiducial Markers Market Value (US$ Mn) Forecast by Country, 2015-2030

Table 52: South Asia Fiducial Markers Market Volume (Units) Forecast by Country, 2015-2030

Table 53: South Asia Fiducial Markers Market Value (US$ Mn) Forecast by Product Type, 2015-2030

Table 54: South Asia Fiducial Markers Market Volume (Units) Forecast by Product Type, 2015-2030

Table 55: South Asia Fiducial Markers Market Value (US$ Mn) Forecast by Modality, 2015-2030

Table 56: South Asia Fiducial Markers Market Volume (Units) Forecast by Modality, 2015-2030

Table 57: South Asia Fiducial Markers Market Value (US$ Mn) Forecast by Disease Site, 2015-2030

Table 58: South Asia Fiducial Markers Market Volume (Units) Forecast by Disease Site, 2015-2030

Table 59: South Asia Fiducial Markers Market Value (US$ Mn) Forecast by End Users, 2015-2030

Table 60: South Asia Fiducial Markers Market Volume (Units) Forecast by End Users, 2015-2030

Table 61: Oceania Fiducial Markers Market Value (US$ Mn) Forecast by Country, 2015-2030

Table 62: Oceania Fiducial Markers Market Volume (Units) Forecast by Country, 2015-2030

Table 63: Oceania Fiducial Markers Market Value (US$ Mn) Forecast by Product Type, 2015-2030

Table 64: Oceania Fiducial Markers Market Volume (Units) Forecast by Product Type, 2015-2030

Table 65: Oceania Fiducial Markers Market Value (US$ Mn) Forecast by Modality, 2015-2030

Table 66: Oceania Fiducial Markers Market Volume (Units) Forecast by Modality, 2015-2030

Table 67: Oceania Fiducial Markers Market Value (US$ Mn) Forecast by Disease Site, 2015-2030

Table 68: Oceania Fiducial Markers Market Volume (Units) Forecast by Disease Site, 2015-2030

Table 69: Oceania Fiducial Markers Market Value (US$ Mn) Forecast by End Users, 2015-2030

Table 70: Oceania Fiducial Markers Market Volume (Units) Forecast by End Users, 2015-2030

Table 71: Middle East & Africa (MEA) Fiducial Markers Market Value (US$ Mn) Forecast by Country, 2015-2030

Table 72: Middle East & Africa (MEA) Fiducial Markers Market Volume (Units) Forecast by Country, 2015-2030

Table 73: Middle East & Africa (MEA) Fiducial Markers Market Value (US$ Mn) Forecast by Product Type, 2015-2030

Table 74: Middle East & Africa (MEA) Fiducial Markers Market Volume (Units) Forecast by Product Type, 2015-2030

Table 75: Middle East & Africa (MEA) Fiducial Markers Market Value (US$ Mn) Forecast by Modality, 2015-2030

Table 76: Middle East & Africa (MEA) Fiducial Markers Market Volume (Units) Forecast by Modality, 2015-2030

Table 77: Middle East & Africa (MEA) Fiducial Markers Market Value (US$ Mn) Forecast by Disease Site, 2015-2030

Table 78: Middle East & Africa (MEA) Fiducial Markers Market Volume (Units) Forecast by Disease Site, 2015-2030

Table 79: Middle East & Africa (MEA) Fiducial Markers Market Value (US$ Mn) Forecast by End Users, 2015-2030

Table 80: Middle East & Africa (MEA) Fiducial Markers Market Volume (Units) Forecast by End Users, 2015-2030

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Fiducial Markers Market Value (US$ Mn) by Product Type, 2022-2030

Figure 2: Global Fiducial Markers Market Value (US$ Mn) by Modality, 2022-2030

Figure 3: Global Fiducial Markers Market Value (US$ Mn) by Disease Site, 2022-2030

Figure 4: Global Fiducial Markers Market Value (US$ Mn) by End Users, 2022-2030

Figure 5: Global Fiducial Markers Market Value (US$ Mn) by Region, 2022-2030

Figure 6: Global Fiducial Markers Market Value (US$ Mn) Analysis by Region, 2015-2030

Figure 7: Global Fiducial Markers Market Volume (Units) Analysis by Region, 2015-2030

Figure 8: Global Fiducial Markers Market Value Share (%) by Region, 2022-2030

Figure 9: Global Fiducial Markers Market Y-o-Y Growth (%) Projections by Region, 2022-2030

Figure 10: Global Fiducial Markers Market Value (US$ Mn) Analysis by Product Type, 2015-2030

Figure 11: Global Fiducial Markers Market Volume (Units) Analysis by Product Type, 2015-2030

Figure 12: Global Fiducial Markers Market Value Share (%) by Product Type, 2022-2030

Figure 13: Global Fiducial Markers Market Y-o-Y Growth (%) Projections by Product Type, 2022-2030

Figure 14: Global Fiducial Markers Market Value (US$ Mn) Analysis by Modality, 2015-2030

Figure 15: Global Fiducial Markers Market Volume (Units) Analysis by Modality, 2015-2030

Figure 16: Global Fiducial Markers Market Value Share (%) by Modality, 2022-2030

Figure 17: Global Fiducial Markers Market Y-o-Y Growth (%) Projections by Modality, 2022-2030

Figure 18: Global Fiducial Markers Market Value (US$ Mn) Analysis by Disease Site, 2015-2030

Figure 19: Global Fiducial Markers Market Volume (Units) Analysis by Disease Site, 2015-2030

Figure 20: Global Fiducial Markers Market Value Share (%) by Disease Site, 2022-2030

Figure 21: Global Fiducial Markers Market Y-o-Y Growth (%) Projections by Disease Site, 2022-2030

Figure 22: Global Fiducial Markers Market Value (US$ Mn) Analysis by End Users, 2015-2030

Figure 23: Global Fiducial Markers Market Volume (Units) Analysis by End Users, 2015-2030

Figure 24: Global Fiducial Markers Market Value Share (%) by End Users, 2022-2030

Figure 25: Global Fiducial Markers Market Y-o-Y Growth (%) Projections by End Users, 2022-2030

Figure 26: Global Fiducial Markers Market Attractiveness by Product Type, 2022-2030

Figure 27: Global Fiducial Markers Market Attractiveness by Modality, 2022-2030

Figure 28: Global Fiducial Markers Market Attractiveness by Disease Site, 2022-2030

Figure 29: Global Fiducial Markers Market Attractiveness by End Users, 2022-2030

Figure 30: Global Fiducial Markers Market Attractiveness by Region, 2022-2030

Figure 31: North America Fiducial Markers Market Value (US$ Mn) by Product Type, 2022-2030

Figure 32: North America Fiducial Markers Market Value (US$ Mn) by Modality, 2022-2030

Figure 33: North America Fiducial Markers Market Value (US$ Mn) by Disease Site, 2022-2030

Figure 34: North America Fiducial Markers Market Value (US$ Mn) by End Users, 2022-2030

Figure 35: North America Fiducial Markers Market Value (US$ Mn) by Country, 2022-2030

Figure 36: North America Fiducial Markers Market Value (US$ Mn) Analysis by Country, 2015-2030

Figure 37: North America Fiducial Markers Market Volume (Units) Analysis by Country, 2015-2030

Figure 38: North America Fiducial Markers Market Value Share (%) by Country, 2022-2030

Figure 39: North America Fiducial Markers Market Y-o-Y Growth (%) Projections by Country, 2022-2030

Figure 40: North America Fiducial Markers Market Value (US$ Mn) Analysis by Product Type, 2015-2030

Figure 41: North America Fiducial Markers Market Volume (Units) Analysis by Product Type, 2015-2030

Figure 42: North America Fiducial Markers Market Value Share (%) by Product Type, 2022-2030

Figure 43: North America Fiducial Markers Market Y-o-Y Growth (%) Projections by Product Type, 2022-2030

Figure 44: North America Fiducial Markers Market Value (US$ Mn) Analysis by Modality, 2015-2030

Figure 45: North America Fiducial Markers Market Volume (Units) Analysis by Modality, 2015-2030

Figure 46: North America Fiducial Markers Market Value Share (%) by Modality, 2022-2030

Figure 47: North America Fiducial Markers Market Y-o-Y Growth (%) Projections by Modality, 2022-2030

Figure 48: North America Fiducial Markers Market Value (US$ Mn) Analysis by Disease Site, 2015-2030

Figure 49: North America Fiducial Markers Market Volume (Units) Analysis by Disease Site, 2015-2030

Figure 50: North America Fiducial Markers Market Value Share (%) by Disease Site, 2022-2030

Figure 51: North America Fiducial Markers Market Y-o-Y Growth (%) Projections by Disease Site, 2022-2030

Figure 52: North America Fiducial Markers Market Value (US$ Mn) Analysis by End Users, 2015-2030

Figure 53: North America Fiducial Markers Market Volume (Units) Analysis by End Users, 2015-2030

Figure 54: North America Fiducial Markers Market Value Share (%) by End Users, 2022-2030

Figure 55: North America Fiducial Markers Market Y-o-Y Growth (%) Projections by End Users, 2022-2030

Figure 56: North America Fiducial Markers Market Attractiveness by Product Type, 2022-2030

Figure 57: North America Fiducial Markers Market Attractiveness by Modality, 2022-2030

Figure 58: North America Fiducial Markers Market Attractiveness by Disease Site, 2022-2030

Figure 59: North America Fiducial Markers Market Attractiveness by End Users, 2022-2030

Figure 60: North America Fiducial Markers Market Attractiveness by Country, 2022-2030

Figure 61: Latin America Fiducial Markers Market Value (US$ Mn) by Product Type, 2022-2030

Figure 62: Latin America Fiducial Markers Market Value (US$ Mn) by Modality, 2022-2030

Figure 63: Latin America Fiducial Markers Market Value (US$ Mn) by Disease Site, 2022-2030

Figure 64: Latin America Fiducial Markers Market Value (US$ Mn) by End Users, 2022-2030

Figure 65: Latin America Fiducial Markers Market Value (US$ Mn) by Country, 2022-2030

Figure 66: Latin America Fiducial Markers Market Value (US$ Mn) Analysis by Country, 2015-2030

Figure 67: Latin America Fiducial Markers Market Volume (Units) Analysis by Country, 2015-2030

Figure 68: Latin America Fiducial Markers Market Value Share (%) by Country, 2022-2030

Figure 69: Latin America Fiducial Markers Market Y-o-Y Growth (%) Projections by Country, 2022-2030

Figure 70: Latin America Fiducial Markers Market Value (US$ Mn) Analysis by Product Type, 2015-2030

Figure 71: Latin America Fiducial Markers Market Volume (Units) Analysis by Product Type, 2015-2030

Figure 72: Latin America Fiducial Markers Market Value Share (%) by Product Type, 2022-2030

Figure 73: Latin America Fiducial Markers Market Y-o-Y Growth (%) Projections by Product Type, 2022-2030

Figure 74: Latin America Fiducial Markers Market Value (US$ Mn) Analysis by Modality, 2015-2030

Figure 75: Latin America Fiducial Markers Market Volume (Units) Analysis by Modality, 2015-2030

Figure 76: Latin America Fiducial Markers Market Value Share (%) by Modality, 2022-2030

Figure 77: Latin America Fiducial Markers Market Y-o-Y Growth (%) Projections by Modality, 2022-2030

Figure 78: Latin America Fiducial Markers Market Value (US$ Mn) Analysis by Disease Site, 2015-2030

Figure 79: Latin America Fiducial Markers Market Volume (Units) Analysis by Disease Site, 2015-2030

Figure 80: Latin America Fiducial Markers Market Value Share (%) by Disease Site, 2022-2030

Figure 81: Latin America Fiducial Markers Market Y-o-Y Growth (%) Projections by Disease Site, 2022-2030

Figure 82: Latin America Fiducial Markers Market Value (US$ Mn) Analysis by End Users, 2015-2030

Figure 83: Latin America Fiducial Markers Market Volume (Units) Analysis by End Users, 2015-2030

Figure 84: Latin America Fiducial Markers Market Value Share (%) by End Users, 2022-2030

Figure 85: Latin America Fiducial Markers Market Y-o-Y Growth (%) Projections by End Users, 2022-2030

Figure 86: Latin America Fiducial Markers Market Attractiveness by Product Type, 2022-2030

Figure 87: Latin America Fiducial Markers Market Attractiveness by Modality, 2022-2030

Figure 88: Latin America Fiducial Markers Market Attractiveness by Disease Site, 2022-2030

Figure 89: Latin America Fiducial Markers Market Attractiveness by End Users, 2022-2030

Figure 90: Latin America Fiducial Markers Market Attractiveness by Country, 2022-2030

Figure 91: Europe Fiducial Markers Market Value (US$ Mn) by Product Type, 2022-2030

Figure 92: Europe Fiducial Markers Market Value (US$ Mn) by Modality, 2022-2030

Figure 93: Europe Fiducial Markers Market Value (US$ Mn) by Disease Site, 2022-2030

Figure 94: Europe Fiducial Markers Market Value (US$ Mn) by End Users, 2022-2030

Figure 95: Europe Fiducial Markers Market Value (US$ Mn) by Country, 2022-2030

Figure 96: Europe Fiducial Markers Market Value (US$ Mn) Analysis by Country, 2015-2030

Figure 97: Europe Fiducial Markers Market Volume (Units) Analysis by Country, 2015-2030

Figure 98: Europe Fiducial Markers Market Value Share (%) by Country, 2022-2030

Figure 99: Europe Fiducial Markers Market Y-o-Y Growth (%) Projections by Country, 2022-2030

Figure 100: Europe Fiducial Markers Market Value (US$ Mn) Analysis by Product Type, 2015-2030

Figure 101: Europe Fiducial Markers Market Volume (Units) Analysis by Product Type, 2015-2030

Figure 102: Europe Fiducial Markers Market Value Share (%) by Product Type, 2022-2030

Figure 103: Europe Fiducial Markers Market Y-o-Y Growth (%) Projections by Product Type, 2022-2030

Figure 104: Europe Fiducial Markers Market Value (US$ Mn) Analysis by Modality, 2015-2030

Figure 105: Europe Fiducial Markers Market Volume (Units) Analysis by Modality, 2015-2030

Figure 106: Europe Fiducial Markers Market Value Share (%) by Modality, 2022-2030

Figure 107: Europe Fiducial Markers Market Y-o-Y Growth (%) Projections by Modality, 2022-2030

Figure 108: Europe Fiducial Markers Market Value (US$ Mn) Analysis by Disease Site, 2015-2030

Figure 109: Europe Fiducial Markers Market Volume (Units) Analysis by Disease Site, 2015-2030

Figure 110: Europe Fiducial Markers Market Value Share (%) by Disease Site, 2022-2030

Figure 111: Europe Fiducial Markers Market Y-o-Y Growth (%) Projections by Disease Site, 2022-2030

Figure 112: Europe Fiducial Markers Market Value (US$ Mn) Analysis by End Users, 2015-2030

Figure 113: Europe Fiducial Markers Market Volume (Units) Analysis by End Users, 2015-2030

Figure 114: Europe Fiducial Markers Market Value Share (%) by End Users, 2022-2030

Figure 115: Europe Fiducial Markers Market Y-o-Y Growth (%) Projections by End Users, 2022-2030

Figure 116: Europe Fiducial Markers Market Attractiveness by Product Type, 2022-2030

Figure 117: Europe Fiducial Markers Market Attractiveness by Modality, 2022-2030

Figure 118: Europe Fiducial Markers Market Attractiveness by Disease Site, 2022-2030

Figure 119: Europe Fiducial Markers Market Attractiveness by End Users, 2022-2030

Figure 120: Europe Fiducial Markers Market Attractiveness by Country, 2022-2030

Figure 121: East Asia Fiducial Markers Market Value (US$ Mn) by Product Type, 2022-2030

Figure 122: East Asia Fiducial Markers Market Value (US$ Mn) by Modality, 2022-2030

Figure 123: East Asia Fiducial Markers Market Value (US$ Mn) by Disease Site, 2022-2030

Figure 124: East Asia Fiducial Markers Market Value (US$ Mn) by End Users, 2022-2030

Figure 125: East Asia Fiducial Markers Market Value (US$ Mn) by Country, 2022-2030

Figure 126: East Asia Fiducial Markers Market Value (US$ Mn) Analysis by Country, 2015-2030

Figure 127: East Asia Fiducial Markers Market Volume (Units) Analysis by Country, 2015-2030

Figure 128: East Asia Fiducial Markers Market Value Share (%) by Country, 2022-2030

Figure 129: East Asia Fiducial Markers Market Y-o-Y Growth (%) Projections by Country, 2022-2030

Figure 130: East Asia Fiducial Markers Market Value (US$ Mn) Analysis by Product Type, 2015-2030

Figure 131: East Asia Fiducial Markers Market Volume (Units) Analysis by Product Type, 2015-2030

Figure 132: East Asia Fiducial Markers Market Value Share (%) by Product Type, 2022-2030

Figure 133: East Asia Fiducial Markers Market Y-o-Y Growth (%) Projections by Product Type, 2022-2030

Figure 134: East Asia Fiducial Markers Market Value (US$ Mn) Analysis by Modality, 2015-2030

Figure 135: East Asia Fiducial Markers Market Volume (Units) Analysis by Modality, 2015-2030

Figure 136: East Asia Fiducial Markers Market Value Share (%) by Modality, 2022-2030

Figure 137: East Asia Fiducial Markers Market Y-o-Y Growth (%) Projections by Modality, 2022-2030

Figure 138: East Asia Fiducial Markers Market Value (US$ Mn) Analysis by Disease Site, 2015-2030

Figure 139: East Asia Fiducial Markers Market Volume (Units) Analysis by Disease Site, 2015-2030

Figure 140: East Asia Fiducial Markers Market Value Share (%) by Disease Site, 2022-2030

Figure 141: East Asia Fiducial Markers Market Y-o-Y Growth (%) Projections by Disease Site, 2022-2030

Figure 142: East Asia Fiducial Markers Market Value (US$ Mn) Analysis by End Users, 2015-2030

Figure 143: East Asia Fiducial Markers Market Volume (Units) Analysis by End Users, 2015-2030

Figure 144: East Asia Fiducial Markers Market Value Share (%) by End Users, 2022-2030

Figure 145: East Asia Fiducial Markers Market Y-o-Y Growth (%) Projections by End Users, 2022-2030

Figure 146: East Asia Fiducial Markers Market Attractiveness by Product Type, 2022-2030

Figure 147: East Asia Fiducial Markers Market Attractiveness by Modality, 2022-2030

Figure 148: East Asia Fiducial Markers Market Attractiveness by Disease Site, 2022-2030

Figure 149: East Asia Fiducial Markers Market Attractiveness by End Users, 2022-2030

Figure 150: East Asia Fiducial Markers Market Attractiveness by Country, 2022-2030

Figure 151: South Asia Fiducial Markers Market Value (US$ Mn) by Product Type, 2022-2030

Figure 152: South Asia Fiducial Markers Market Value (US$ Mn) by Modality, 2022-2030

Figure 153: South Asia Fiducial Markers Market Value (US$ Mn) by Disease Site, 2022-2030

Figure 154: South Asia Fiducial Markers Market Value (US$ Mn) by End Users, 2022-2030

Figure 155: South Asia Fiducial Markers Market Value (US$ Mn) by Country, 2022-2030

Figure 156: South Asia Fiducial Markers Market Value (US$ Mn) Analysis by Country, 2015-2030

Figure 157: South Asia Fiducial Markers Market Volume (Units) Analysis by Country, 2015-2030

Figure 158: South Asia Fiducial Markers Market Value Share (%) by Country, 2022-2030

Figure 159: South Asia Fiducial Markers Market Y-o-Y Growth (%) Projections by Country, 2022-2030

Figure 160: South Asia Fiducial Markers Market Value (US$ Mn) Analysis by Product Type, 2015-2030

Figure 161: South Asia Fiducial Markers Market Volume (Units) Analysis by Product Type, 2015-2030

Figure 162: South Asia Fiducial Markers Market Value Share (%) by Product Type, 2022-2030

Figure 163: South Asia Fiducial Markers Market Y-o-Y Growth (%) Projections by Product Type, 2022-2030

Figure 164: South Asia Fiducial Markers Market Value (US$ Mn) Analysis by Modality, 2015-2030

Figure 165: South Asia Fiducial Markers Market Volume (Units) Analysis by Modality, 2015-2030

Figure 166: South Asia Fiducial Markers Market Value Share (%) by Modality, 2022-2030

Figure 167: South Asia Fiducial Markers Market Y-o-Y Growth (%) Projections by Modality, 2022-2030

Figure 168: South Asia Fiducial Markers Market Value (US$ Mn) Analysis by Disease Site, 2015-2030

Figure 169: South Asia Fiducial Markers Market Volume (Units) Analysis by Disease Site, 2015-2030

Figure 170: South Asia Fiducial Markers Market Value Share (%) by Disease Site, 2022-2030

Figure 171: South Asia Fiducial Markers Market Y-o-Y Growth (%) Projections by Disease Site, 2022-2030

Figure 172: South Asia Fiducial Markers Market Value (US$ Mn) Analysis by End Users, 2015-2030

Figure 173: South Asia Fiducial Markers Market Volume (Units) Analysis by End Users, 2015-2030

Figure 174: South Asia Fiducial Markers Market Value Share (%) by End Users, 2022-2030

Figure 175: South Asia Fiducial Markers Market Y-o-Y Growth (%) Projections by End Users, 2022-2030

Figure 176: South Asia Fiducial Markers Market Attractiveness by Product Type, 2022-2030

Figure 177: South Asia Fiducial Markers Market Attractiveness by Modality, 2022-2030

Figure 178: South Asia Fiducial Markers Market Attractiveness by Disease Site, 2022-2030

Figure 179: South Asia Fiducial Markers Market Attractiveness by End Users, 2022-2030

Figure 180: South Asia Fiducial Markers Market Attractiveness by Country, 2022-2030

Figure 181: Oceania Fiducial Markers Market Value (US$ Mn) by Product Type, 2022-2030

Figure 182: Oceania Fiducial Markers Market Value (US$ Mn) by Modality, 2022-2030

Figure 183: Oceania Fiducial Markers Market Value (US$ Mn) by Disease Site, 2022-2030

Figure 184: Oceania Fiducial Markers Market Value (US$ Mn) by End Users, 2022-2030

Figure 185: Oceania Fiducial Markers Market Value (US$ Mn) by Country, 2022-2030

Figure 186: Oceania Fiducial Markers Market Value (US$ Mn) Analysis by Country, 2015-2030

Figure 187: Oceania Fiducial Markers Market Volume (Units) Analysis by Country, 2015-2030

Figure 188: Oceania Fiducial Markers Market Value Share (%) by Country, 2022-2030

Figure 189: Oceania Fiducial Markers Market Y-o-Y Growth (%) Projections by Country, 2022-2030

Figure 190: Oceania Fiducial Markers Market Value (US$ Mn) Analysis by Product Type, 2015-2030

Figure 191: Oceania Fiducial Markers Market Volume (Units) Analysis by Product Type, 2015-2030

Figure 192: Oceania Fiducial Markers Market Value Share (%) by Product Type, 2022-2030

Figure 193: Oceania Fiducial Markers Market Y-o-Y Growth (%) Projections by Product Type, 2022-2030

Figure 194: Oceania Fiducial Markers Market Value (US$ Mn) Analysis by Modality, 2015-2030

Figure 195: Oceania Fiducial Markers Market Volume (Units) Analysis by Modality, 2015-2030

Figure 196: Oceania Fiducial Markers Market Value Share (%) by Modality, 2022-2030

Figure 197: Oceania Fiducial Markers Market Y-o-Y Growth (%) Projections by Modality, 2022-2030

Figure 198: Oceania Fiducial Markers Market Value (US$ Mn) Analysis by Disease Site, 2015-2030

Figure 199: Oceania Fiducial Markers Market Volume (Units) Analysis by Disease Site, 2015-2030

Figure 200: Oceania Fiducial Markers Market Value Share (%) by Disease Site, 2022-2030

Figure 201: Oceania Fiducial Markers Market Y-o-Y Growth (%) Projections by Disease Site, 2022-2030

Figure 202: Oceania Fiducial Markers Market Value (US$ Mn) Analysis by End Users, 2015-2030

Figure 203: Oceania Fiducial Markers Market Volume (Units) Analysis by End Users, 2015-2030

Figure 204: Oceania Fiducial Markers Market Value Share (%) by End Users, 2022-2030

Figure 205: Oceania Fiducial Markers Market Y-o-Y Growth (%) Projections by End Users, 2022-2030

Figure 206: Oceania Fiducial Markers Market Attractiveness by Product Type, 2022-2030

Figure 207: Oceania Fiducial Markers Market Attractiveness by Modality, 2022-2030

Figure 208: Oceania Fiducial Markers Market Attractiveness by Disease Site, 2022-2030

Figure 209: Oceania Fiducial Markers Market Attractiveness by End Users, 2022-2030

Figure 210: Oceania Fiducial Markers Market Attractiveness by Country, 2022-2030

Figure 211: Middle East & Africa (MEA) Fiducial Markers Market Value (US$ Mn) by Product Type, 2022-2030

Figure 212: Middle East & Africa (MEA) Fiducial Markers Market Value (US$ Mn) by Modality, 2022-2030

Figure 213: Middle East & Africa (MEA) Fiducial Markers Market Value (US$ Mn) by Disease Site, 2022-2030

Figure 214: Middle East & Africa (MEA) Fiducial Markers Market Value (US$ Mn) by End Users, 2022-2030

Figure 215: Middle East & Africa (MEA) Fiducial Markers Market Value (US$ Mn) by Country, 2022-2030

Figure 216: Middle East & Africa (MEA) Fiducial Markers Market Value (US$ Mn) Analysis by Country, 2015-2030

Figure 217: Middle East & Africa (MEA) Fiducial Markers Market Volume (Units) Analysis by Country, 2015-2030

Figure 218: Middle East & Africa (MEA) Fiducial Markers Market Value Share (%) by Country, 2022-2030

Figure 219: Middle East & Africa (MEA) Fiducial Markers Market Y-o-Y Growth (%) Projections by Country, 2022-2030

Figure 220: Middle East & Africa (MEA) Fiducial Markers Market Value (US$ Mn) Analysis by Product Type, 2015-2030

Figure 221: Middle East & Africa (MEA) Fiducial Markers Market Volume (Units) Analysis by Product Type, 2015-2030

Figure 222: Middle East & Africa (MEA) Fiducial Markers Market Value Share (%) by Product Type, 2022-2030

Figure 223: Middle East & Africa (MEA) Fiducial Markers Market Y-o-Y Growth (%) Projections by Product Type, 2022-2030

Figure 224: Middle East & Africa (MEA) Fiducial Markers Market Value (US$ Mn) Analysis by Modality, 2015-2030

Figure 225: Middle East & Africa (MEA) Fiducial Markers Market Volume (Units) Analysis by Modality, 2015-2030

Figure 226: Middle East & Africa (MEA) Fiducial Markers Market Value Share (%) by Modality, 2022-2030

Figure 227: Middle East & Africa (MEA) Fiducial Markers Market Y-o-Y Growth (%) Projections by Modality, 2022-2030

Figure 228: Middle East & Africa (MEA) Fiducial Markers Market Value (US$ Mn) Analysis by Disease Site, 2015-2030

Figure 229: Middle East & Africa (MEA) Fiducial Markers Market Volume (Units) Analysis by Disease Site, 2015-2030

Figure 230: Middle East & Africa (MEA) Fiducial Markers Market Value Share (%) by Disease Site, 2022-2030

Figure 231: Middle East & Africa (MEA) Fiducial Markers Market Y-o-Y Growth (%) Projections by Disease Site, 2022-2030

Figure 232: Middle East & Africa (MEA) Fiducial Markers Market Value (US$ Mn) Analysis by End Users, 2015-2030

Figure 233: Middle East & Africa (MEA) Fiducial Markers Market Volume (Units) Analysis by End Users, 2015-2030

Figure 234: Middle East & Africa (MEA) Fiducial Markers Market Value Share (%) by End Users, 2022-2030

Figure 235: Middle East & Africa (MEA) Fiducial Markers Market Y-o-Y Growth (%) Projections by End Users, 2022-2030

Figure 236: Middle East & Africa (MEA) Fiducial Markers Market Attractiveness by Product Type, 2022-2030

Figure 237: Middle East & Africa (MEA) Fiducial Markers Market Attractiveness by Modality, 2022-2030

Figure 238: Middle East & Africa (MEA) Fiducial Markers Market Attractiveness by Disease Site, 2022-2030

Figure 239: Middle East & Africa (MEA) Fiducial Markers Market Attractiveness by End Users, 2022-2030

Figure 240: Middle East & Africa (MEA) Fiducial Markers Market Attractiveness by Country, 2022-2030

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Single Dose Radiotherapy Services Market

Published : March 2021

Healthcare

Teleradiology Services Market

Published : November 2016

Healthcare

Radiotherapy Devices Market

Published : August 2017

Healthcare

Radio Frequency Beauty Equipment Market

Published : December 2016

Google translate

Fiducial Markers Market